P3 Health Partners
PIII
47 hedge funds and large institutions have $74.1M invested in P3 Health Partners in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 9 closing their positions.
133% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 9
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
34% more funds holding
Funds holding: 35 → 47 (+12)
0.04% more ownership
Funds ownership: 0.94% → 0.98% (+0.04%)
52% less capital invested
Capital invested by funds: $153M → $74.1M (-$79M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.44M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.45M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.2M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$935K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$587K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$6.13M |
| 2 |
ECM
ExodusPoint Capital Management
New York
|
-$500K |
| 3 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
-$339K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$213K |
| 5 |
Jane Street
New York
|
-$136K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
51
Sciencast Management
Princeton,
New Jersey
| – | -$105K | -275 | Closed |
|
|
MFS
52
Mirabella Financial Services
London,
United Kingdom
| – | -$91K | -232 | Closed |
|
53
Goldman Sachs
New York
| – | -$80K | -203 | Closed |
|
|
OCM
54
Ovata Capital Management
Hong Kong
| – | -$5K | -14 | Closed |
|
|
CS
55
Credit Suisse
Zurich,
Switzerland
| – | +$279 | +1 | New |
|
|
BIA
56
Bell Investment Advisors
Oakland,
California
| – | +$836 | +3 | New |
|
PIII Hedge Fund Activity: Q2 2022 in Review
47 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q2 2022, worth a combined $74.1M — down 52% from $153M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new PIII positions and 9 closed out — a net gain of 12 holders — while 11 added to existing stakes and 7 trimmed.
The largest buyer was BlackRock, adding an estimated $5.44M. The largest seller was Ameriprise, cutting an estimated $6.13M.
- 47 institutional investors held P3 Health Partners (PIII) as of Q2 2022, up from 35 in Q1 2022.
- Funds reported $74.1M of P3 Health Partners stock for Q2 2022, down 52% quarter-over-quarter.
- 21 funds opened new P3 Health Partners positions in Q2 2022 and 9 closed out, a net change of +12 holders.
- The largest P3 Health Partners buyer in Q2 2022 was BlackRock, an estimated $5.44M added.
- The largest P3 Health Partners seller in Q2 2022 was Ameriprise, an estimated $6.13M sold.
Based on aggregated 13F filings for Q2 2022.